Overview
Vogt-Koyanagi-Harada disease is a disorder.
Auto-generated from clinical reference data. Not a substitute for medical advice.
Research Evidence
Peer-reviewed studies linked via MeSH term "Syndrome, Uveomeningoencephalitic" from the MEDLINE/PubMed database.
Sort:
Optical Coherence Tomography Angiography in Vogt-Koyanagi-Harada Patients: A Systematic Review and Meta-Analysis.
[object Object], [object Object], [object Object] et al. · Curr Eye Res · 2024
PMID: 38456233Meta-Analysis
Ocular manifestations of vitiligo: a systematic review.
[object Object], [object Object], [object Object] et al. · BMC Ophthalmol · 2023
Unusual neurologic manifestations of Vogt-Koyanagi-Harada disease: a systematic literature review.
[object Object], [object Object] · BMC Neurol · 2022
Association of human leukocyte antigen (HLA)-DQ and HLA-DQA1/DQB1 alleles with Vogt-Koyanagi-Harada disease: A systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Medicine (Baltimore) · 2018
Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Sci Rep · 2014
Vogt-Koyanagi-Harada syndrome.
[object Object], [object Object], [object Object] et al. · Autoimmun Rev · 2013
PMID: 23567866Meta-Analysis
Effect of prednisone plus either adalimumab or cyclosporine on dermatological symptoms in Vogt-Koyanagi-Harada disease: Systemic outcomes from a randomized trial.
[object Object], [object Object], [object Object] et al. · J Am Acad Dermatol · 2025
PMID: 40043888RCT
Cost-Effectiveness Analysis of Adalimumab Versus Cyclosporine for Vogt-Koyanagi-Harada Disease: A Randomized Controlled Study.
[object Object], [object Object], [object Object] et al. · Curr Eye Res · 2024
PMID: 38783638RCT
Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis Trial.
[object Object], [object Object], [object Object] et al. · Am J Ophthalmol · 2024
PMID: 38909740RCT
A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease.
[object Object], [object Object], [object Object] et al. · Nat Commun · 2023
Search all PubMed articles for Vogt-Koyanagi-Harada disease
Research data from MEDLINE/PubMed
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Abnormality of the eyebrow
Very frequent (80-99%)HP:0000534
Abnormality of the eyelashes
Very frequent (80-99%)HP:0000499
Blotchy loss of skin colour
Very frequent (80-99%)HP:0001045
Cerebrospinal fluid pleocytosis
Very frequent (80-99%)HP:0012229
Headache
Very frequent (80-99%)HP:0002315
Hypopigmented skin patches
Very frequent (80-99%)HP:0001053
Intellectual impairment
Very frequent (80-99%)HP:0100543
Patch of white hair
Very frequent (80-99%)HP:0002290
Premature graying of the hair
Very frequent (80-99%)HP:0002216
Thinning scalp hair
Very frequent (80-99%)HP:0002209
Blurred vision
Frequent (30-79%)HP:0000622
Chorioretinal hypopigmentation
Frequent (30-79%)HP:0040030
Conjunctival hyperemia
Frequent (30-79%)HP:0030953
Decreased body height
Frequent (30-79%)HP:0004322
Elevated IOP
Frequent (30-79%)HP:0007906
Iridocyclitis
Frequent (30-79%)HP:0001094
Lens opacities
Frequent (30-79%)HP:0000518
Meningism
Frequent (30-79%)HP:0031179
Poor vision
Frequent (30-79%)HP:0000505
Posterior subcapsular cataracts
Frequent (30-79%)HP:0007787
Retinal detachment
Frequent (30-79%)HP:0000541
Retinal nerve fiber edema
Frequent (30-79%)HP:0020120
Ringing in ears
Frequent (30-79%)HP:0000360
Sensorineural deafness
Frequent (30-79%)HP:0000407
Uveitis
Frequent (30-79%)HP:0000554
Allodynia of scalp
Occasional (5-29%)HP:0100809
Corneal keratic precipitates
Occasional (5-29%)HP:0025341
Dalen Fuchs nodules
Occasional (5-29%)HP:6000710
Difficulty finding words
Occasional (5-29%)HP:0002381
Dizziness
Occasional (5-29%)HP:0002321
Quick Facts
- SNOMED CT
- 193497004
- UMLS CUI
- C0042170
- Fully Specified Name
- Vogt-Koyanagi-Harada disease (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 30
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.